Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment
NCT ID: NCT03530098
Last Updated: 2021-06-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1903 participants
INTERVENTIONAL
2018-07-12
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence Assisted Bone Age Assessment
NCT07121283
Clinical Validation of Boneview for FDA Submission
NCT04532580
Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray
NCT03123003
Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers
NCT03076658
Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning
NCT07162168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is organized as a multi-institutional randomized control trial with two arms - experiment (receiving the Artificial Intelligence algorithm's output) and control (no intervention). Both of these arms will be compared to a clinical reference standard ("gold standard") composed of a panel of radiologists. The metric of comparison will be Mean Absolute Distance (MAD). The investigators plan to use statistical tests such as the t-test to determine any statistically-significant difference in skeletal age estimation between the two groups.
The investigators have recruited and analyzed data from a sample size of 1600 exams. Patients getting these exams will not undergo any research procedures that deviate from the current standard practices.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (Without-AI)
This is the control arm where no intervention is provided; represents current standard of care.
No interventions assigned to this group
Experiment (With-AI)
This is the experiment arm where the intervention, "BoneAgeModel", is provided. The participating radiologists in this arm will receive the output of the Artificial Intelligence algorithm. They will be asked to incorporate this new information with their normal workflows to make a diagnosis. The radiologists' diagnosis will be considered final.
BoneAgeModel
BoneAgeModel is an Artificial Intelligence tool that takes in a hand radiograph and gender, and outputs the skeletal (bone) age. The intervention involves using this tool as a factor in the clinical decision making process of the participating radiologists. The radiologist's decision will be considered final.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BoneAgeModel
BoneAgeModel is an Artificial Intelligence tool that takes in a hand radiograph and gender, and outputs the skeletal (bone) age. The intervention involves using this tool as a factor in the clinical decision making process of the participating radiologists. The radiologist's decision will be considered final.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exams containing more than one radiograph will not be included. Exams for which a trainee provides a preliminary interpretation will be excluded. No further exclusion criteria will be applied on the basis of image quality metrics or manufacturers. No exclusion criteria will be applied on the basis of patient chronological age.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Safwan S Halabi, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Curtis Langlotz, M.D. Ph.D.
Role: STUDY_CHAIR
Stanford University
David Eng, B.S.
Role: STUDY_DIRECTOR
Stanford University
Nishith Khandwala, B.S.
Role: STUDY_DIRECTOR
Stanford University
Safwan Halabi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Boston Children's Hospital
Boston, Massachusetts, United States
New York University
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB #44764
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.